Chi-Med's Surufatinib, Generic Ibrance Among Latest China Approvals

Large Batch Of Late 2020 Nods

 
• By Brian Yang
  
Form close up, fountain pen and approved stamped on a document. Soft focus. - Image
CHINA CONTINUES NEW DRUG APPROVAL SPURT • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia